Sterile Compounding Pharmacies Market Share, Size, and Trends by 2028
Sterile Compounding Pharmacies Market: Strategic Insights
Sterile Compounding Pharmacies Market
-
CAGR (2021 - 2028)6.6% -
Market Size 2021
US$ 3.97 Billion -
Market Size 2028
US$ 6.2 Billion
Market Dynamics
GROWTH DRIVERS
- Rising demand for customized medications
- Growth in chronic disease treatments
- Stringent regulatory standards for sterility
FUTURE TRENDS
- Adoption of automated compounding systems
- Increased focus on personalized therapies
- Enhanced quality control measures
OPPORTUNITIES
- Growth in outsourced pharmacy services
- Development in oncology-specific compounding
- Expansion in pediatric formulations
Key Players
- Fagron Inc
- Triangle Compounding Pharmacy
- B Braun Melsungen AG
- PharMedium Healthcare Holdings Inc
- Fresenious Kabi AG
- Avella Specialty Pharmacy
- Pencol Compounding Pharmacy
- Pavilion Compounding Pharmacy LLC
- Pace Pharmacy
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Injectable Drugs and Infusions
Route of Administration
- Intravenous
- Intramuscular
- Subcutaneous